West Pharmaceutical Services (NYSE:WST) Issues Earnings Results

West Pharmaceutical Services (NYSE:WST) posted its earnings results on Thursday. The medical instruments supplier reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.51 by $0.34, Briefing.com reports. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The business had revenue of $746.90 million for the quarter, compared to the consensus estimate of $709.62 million. During the same quarter last year, the firm posted $2.16 EPS. The company’s revenue for the quarter was down .1% on a year-over-year basis. West Pharmaceutical Services updated its FY 2024 guidance to 6.550-6.750 EPS and its FY24 guidance to $6.55 to $6.75 EPS.

West Pharmaceutical Services Stock Down 6.9 %

Shares of NYSE WST opened at $307.92 on Friday. West Pharmaceutical Services has a 12-month low of $265.00 and a 12-month high of $413.70. The stock’s fifty day simple moving average is $300.51 and its two-hundred day simple moving average is $321.78. The stock has a market capitalization of $22.43 billion, a PE ratio of 40.62, a price-to-earnings-growth ratio of 10.21 and a beta of 1.01. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03.

West Pharmaceutical Services Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 20th. Investors of record on Wednesday, November 13th will be paid a $0.21 dividend. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. West Pharmaceutical Services’s payout ratio is 11.08%.

Insider Transactions at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $300.00, for a total transaction of $308,700.00. Following the sale, the vice president now owns 1,478 shares of the company’s stock, valued at $443,400. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.53% of the company’s stock.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.